Understanding how CCN5/WISP2 is regulated and signals is important and may be useful for developing new treatment strategies in obesity and metabolic diseases and it can also be a target in regenerative medicine. This evidence concerns the gene CCN5 and obesity due to melanocortin 4 receptor deficiency.